By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bavarian Nordic A/S 

Vesterbrogade 149

Copenhagen    DK-1620  Denmark
Phone: 45-3326-8383 Fax: 45-3326-8380




Company News
Bavarian Nordic (BAVA.CO) Announces Collaboration To Evaluate CV301 And Tecentriq In Bladder Cancer 3/10/2017 7:12:55 AM
Bavarian Nordic (BAVA.CO) Initiates Trial Of CV301 In Combination With Nivolumab In Patients With Lung Cancer 12/29/2016 8:53:39 AM
Bavarian Nordic (BAVA.CO) Announces Initiation Of Phase 2 Combination Trial Of PROSTVAC And Ipilimumab In Patients With Localized Prostate Cancer 10/10/2016 11:08:15 AM
Bavarian Nordic (BAVA.CO) Appoints Christopher Heery, M.D., As Chief Medical Officer 9/28/2016 9:55:06 AM
Bavarian Nordic (BAVA.CO) Announces That Janssen Has Completed A Submission For Emergency Use Assessment And Listing For Its Ebola Vaccine Regimen To WHO 9/12/2016 11:09:14 AM
Bavarian Nordic (BAVA.CO) Announces Drug Supply Agreement With Bristol-Myers Squibb (BMY) For NSCLC Clinical Study 8/15/2016 9:45:44 AM
Bavarian Nordic (BAVA.CO) Announces Initiation Of NIH Sponsored Phase 1 Trial Of MVA-BN-based Yellow Fever Vaccine 7/27/2016 9:57:28 AM
Bavarian Nordic (BAVA.CO) Announces Expansion Of IMVAMUNE Orders From Canadian Government 6/15/2016 9:42:29 AM
Billion Dollar Biotech Bavarian Nordic (BAVA.CO) Ditches $86 Million U.S. IPO 4/14/2016 6:27:58 AM
Six Biotechs Start Out 2016 By Filing IPOs 1/5/2016 8:13:44 AM